Web Analytics

3 Latest Announced Rounds

$2,265.93M Raised in 95 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Clarametyx Biosciences

start up
United States - Columbus, Ohio
  • 08/01/2024
  • Series A
  • $33,000,000

Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.


Related People

David V. RichardsFounder

David V. Richards United States - Columbus, Ohio

Life sciences executive and entrepreneur with a passion for building transformative science into compelling companies. Focus on high patient need categories that hold the potential for broad impact on national and global health, with a personal interest in infectious disease, neurocognitive and genetic disorders.